Danny Hsu: Fascinating Insight into the Cellular Mechanisms of Statins in APLS
Danny Hsu, President of THANZ, reposted from Journal of Thrombosis and Haemostasis (JTH) on LinkedIn:
”Fascinating insight into the cellular mechanisms of statins in APLS.”
Quoting Journal of Thrombosis and Haemostasis (JTH)‘s post:
”Simvastatin competitively inhibits cellular signaling of lipid-binding antiphospholipid antibodies
By Dominika Marova, Paul Frankenbach, Dr. Anne Hollerbach, Susanne Strand, Wolfram Ruf, Karl Lackner, and Nadine Müller Calleja
Antiphospholipid antibodies (aPLs) drive thrombosis and inflammation via endothelial protein C-receptor (EPCR)–mediated binding of lysobisphosphatidic acid (LBPA).
Statins may exert direct anti-APS effects through molecular competition at EPCR–lipid interfaces, not merely via lipid-lowering or pleiotropic vascular actions.”
Read the full article here.
Article: Simvastatin competitively inhibits cellular signaling of lipid-binding antiphospholipid antibodies
Authors: Dominika Marova, Paul Frankenbach, Anne Hollerbach, Susanne Strand, Wolfram Ruf, Karl J. Lackner, Nadine Müller-Calleja
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 09:18Shamee Shastry: How Transfusion Medicine Research Is Evolving in India
-
Sep 22, 2026, 09:11Tarique Shahzad Chachar: Why Warfarin Remains the Gold Standard for Mechanical Heart Valves
-
Sep 22, 2026, 09:04Bianca Rocca: Thromboinflammatory Injury in Ischemic Limb Necrosis During Severe Shock
-
Sep 22, 2026, 09:01Ash Paul: Comparing Left Atrial Appendage Occlusion and Oral Anticoagulation
-
Sep 22, 2026, 08:50Emily Horner: Lipoprotein(a) Links Oxidized Phospholipids to Platelet Hyperactivity
-
Sep 22, 2026, 08:42Sally Mandour: Bone Marrow Needle Gauge Explained
-
Sep 22, 2026, 08:39Alessandro Sionis: Navigating Anticoagulation in Mechanical Circulatory Support
-
Sep 22, 2026, 08:28Raghavendra Rao: The Latest Research on Varicose Veins
-
Sep 22, 2026, 08:23Aravind Palraj: Three Essential Tests in Antiphospholipid Syndrome